HOME >> BIOLOGY >> NEWS
USC recipient of stem cell training grants from California Institute for Regenerative Medicine

SACRAMENTO, California--The Keck School of Medicine of the University of Southern California has received a 3-year, $3.16 million stem cell training grant as part of the first round of grants awarded by the California Institute for Regenerative Medicine (CIRM).

The Keck School's grant was called "very thoughtful" by CIRM's Research Funding Working Group and was one of many grants announced here today during a public meeting of the Independent Citizen's Oversight Committee, or ICOC, the group charged with governing CIRM and the way in which it disperses the $3 billion in funding provided it by the passage of the California Stem Cell Research and Cures Initiative in November, 2004.

"This is an exciting moment for the CIRM, as these awards mark the first step in our scientific program of stem cell research--an accomplishment we have been able to achieve in less than one year as a state agency," said Zach Hall, Ph.D., CIRM's interim president. "The CIRM training program established today will be the most comprehensive training program to date in the field. It will provide a pipeline of highly trained basic and clinical investigators for the research that CIRM will fund in California."

"This grant award bodes well for the program we are trying to develop here at the Keck School of Medicine--the USC Institute for Stem Cell and Regenerative Medicine--and speaks highly of the research being conducted here and at Childrens Hospital Los Angeles," said Brian E. Henderson, M.D., dean of the Keck School of Medicine and a member of the ICOC. "But the truth is that the entire research community, and indeed the entire region, stands to benefit from this funding. It really is an extraordinary opportunity, and I'm proud to be a part of it."

The Keck School's Stem Cell Biology Training Grant will be used to train graduate students as well as post-doctoral and clinical fellows across 27 departments at USC, with trainees being recruited from existing Ph.D
'"/>

Contact: Jon Weiner
jon.weiner@usc.edu
323-442-2823
University of Southern California
12-Sep-2005


Page: 1 2 3

Related biology news :

1. ESA announces 2007 award recipients
2. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
3. JDRF announces 2007 Scholar Award recipients
4. PNAS announces 2006 Cozzarelli Prize recipients
5. Wiley Foundation announces recipients of 6th annual Wiley Prize in Biomedical Sciences
6. Long-term cancer risk follows stem cell transplant recipients
7. NIH director announces 2006 Pioneer Award recipients
8. Biophysical Society names 2007 award recipients
9. Biophysical Society names 2007 award recipients
10. Schepens Eye Research Institute scientist is ARVOs 2007 Friedenwald Award recipient
11. 2006 World Food Prize recipients to be recognized at soils congress

Post Your Comments:
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... Water Center today awarded 12 research grants, totaling ... protection efforts. , The two-year grants of up ... to track the remediation of harmful algae blooms; ... weedy plant invasions; study chromosomal damage in tree ... activities. , The grants were awarded to multidisciplinary ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... May 21, 2013 Possible mold re-infestation in ... according to a report from eagletribune.com posted May 14, 2013, ... case the result is positive, My Cleaning Products offered a ... chemical ingredients. , It was said in the Eagle Tribune ... in the campus sparked after a first-grade classroom was closed ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: